Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-21-169432
Filing Date
2021-05-21
Accepted
2021-05-21 17:12:00
Documents
9
Effectiveness Date
2021-05-21

Document Format Files

Seq Description Document Type Size
1 S-8 POS d162734ds8pos.htm S-8 POS 69876
2 EX-4.1 d162734dex41.htm EX-4.1 4206
3 EX-5.1 d162734dex51.htm EX-5.1 5965
4 EX-23.1 d162734dex231.htm EX-23.1 1657
5 EX-23.2 d162734dex232.htm EX-23.2 1641
6 EX-23.3 d162734dex233.htm EX-23.3 1634
7 GRAPHIC g162734dsp12.jpg GRAPHIC 181022
8 GRAPHIC g162734dsp82.jpg GRAPHIC 210722
9 GRAPHIC g162734g67f46.jpg GRAPHIC 4765
  Complete submission text file 0001193125-21-169432.txt   632495
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (858) 633-0300
ImmunityBio, Inc. (Filer) CIK: 0001326110 (see all company filings)

EIN.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-252232 | Film No.: 21950153
SIC: 2836 Biological Products, (No Diagnostic Substances)